Sector

Consumer Staples

47 companies under coverage across 11 industries.

Industries

Browse by industry

Agricultural Products & Services 4 Brewers 2 Consumer Staples Merchandise Retail 6 Distillers & Vintners 1 Food Distributors 3 Food Retail 4 Household Products 4 Packaged Foods & Meats 12 Personal Care Products 4 Soft Drinks & Non-alcoholic Beverages 5 Tobacco 2

Coverage

Consumer Staples companies

Equity Research

Post Holdings Inc (POST)

BUY. 12-month probability-weighted target $86 (+15% vs spot). Gross Margin explains 45% of Monte Carlo outcome variance.

POSTEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +15.9%

Equity Research

General Mills Inc (GIS)

HOLD. 12-month probability-weighted target $35 (+9% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

GISEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +12.9%

Equity Research

Bunge Global SA (BG)

HOLD. 12-month probability-weighted target $114 (+11% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

BGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +12.9%

Equity Research

Hormel Foods Corporation (HRL)

BUY. 12-month probability-weighted target $25 (+30% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

HRLEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +9.1%

Equity Research

Ingredion Incorporated (INGR)

HOLD. 12-month probability-weighted target $104 (+9% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

INGREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.6%

Equity Research

Kimberly-Clark Corporation (KMB)

HOLD. 12-month probability-weighted target $105 (+7% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

KMBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +3.6%

Equity Research

Celsius Holdings Inc (CELH)

HOLD. 12-month probability-weighted target $30 (+4% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

CELHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +0.5%

Equity Research

Kraft Heinz Co (KHC)

HOLD. 12-month probability-weighted target $23 (+2% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

KHCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.3%

Equity Research

The Clorox Company (CLX)

HOLD. 12-month probability-weighted target $93 (+11% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

CLXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.3%

Equity Research

Sprouts Farmers Market LLC (SFM)

HOLD. 12-month probability-weighted target $71 (+9% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

SFMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.4%

Equity Research

PepsiCo Inc (PEP)

HOLD. 12-month probability-weighted target $132 (+4% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

PEPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.6%

Equity Research

Caseys General Stores Inc (CASY)

HOLD. 12-month probability-weighted target $785 (+21% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

CASYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.7%

Equity Research

Kenvue Inc. (KVUE)

HOLD. 12-month probability-weighted target $18 (+0% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

KVUEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.0%

Equity Research

Conagra Brands, Inc. (CAG)

HOLD. 12-month probability-weighted target $13 (-4% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

CAGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.3%

Equity Research

Performance Food Group Co (PFGC)

HOLD. 12-month probability-weighted target $110 (+16% vs spot). Gross Margin explains 75% of Monte Carlo outcome variance.

PFGCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.9%

Equity Research

Tyson Foods Inc (TSN)

HOLD. 12-month probability-weighted target $59 (+11% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

TSNEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.3%

Equity Research

Constellation Brands Inc Class A (STZ)

HOLD. 12-month probability-weighted target $142 (+15% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

STZEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.0%

Equity Research

Maplebear Inc. (CART)

HOLD. 12-month probability-weighted target $45 (-6% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

CARTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.7%

Equity Research

Altria Group (MO)

HOLD. 12-month probability-weighted target $73 (+1% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

MOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.8%

Equity Research

McCormick & Company Incorporated (MKC)

HOLD. 12-month probability-weighted target $49 (+9% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

MKCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.4%

Equity Research

Colgate-Palmolive Company (CL)

HOLD. 12-month probability-weighted target $91 (+3% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

CLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.5%

Equity Research

Procter & Gamble Company (PG)

HOLD. 12-month probability-weighted target $141 (-6% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

PGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.2%

Equity Research

Boston Beer Company Inc (SAM)

HOLD. 12-month probability-weighted target $159 (-7% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SAMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.3%

Equity Research

Hershey Co (HSY)

HOLD. 12-month probability-weighted target $169 (+4% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

HSYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.7%

Equity Research

Molson Coors Brewing Co Class B (TAP)

HOLD. 12-month probability-weighted target $37 (+0% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

TAPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.0%

Equity Research

Kroger Company (KR)

HOLD. 12-month probability-weighted target $59 (-4% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

KREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.6%

Equity Research

Sysco Corporation (SYY)

HOLD. 12-month probability-weighted target $79 (+1% vs spot). Gross Margin explains 70% of Monte Carlo outcome variance.

SYYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.2%

Equity Research

Church & Dwight Company Inc (CHD)

HOLD. 12-month probability-weighted target $95 (-3% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

CHDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.9%

Equity Research

Dollar Tree Inc (DLTR)

HOLD. 12-month probability-weighted target $117 (-1% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

DLTREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.2%

Equity Research

Pilgrims Pride Corp (PPC)

HOLD. 12-month probability-weighted target $28 (-1% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

PPCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.3%

Equity Research

Darling Ingredients Inc (DAR)

HOLD. 12-month probability-weighted target $64 (+5% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

DAREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.8%

Equity Research

Walmart Inc. (WMT)

HOLD. 12-month probability-weighted target $118 (+6% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

WMTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -18.3%

Equity Research

The J. M. Smucker Company (SJM)

HOLD. 12-month probability-weighted target $110 (-8% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

SJMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -18.6%

Equity Research

Costco Wholesale Corp (COST)

HOLD. 12-month probability-weighted target $930 (-2% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

COSTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -19.3%

Equity Research

Target Corporation (TGT)

SELL. 12-month probability-weighted target $138 (-10% vs spot). Gross Margin explains 70% of Monte Carlo outcome variance.

TGTEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.6%

Equity Research

US Foods Holding Corp (USFD)

HOLD. 12-month probability-weighted target $94 (-3% vs spot). Gross Margin explains 70% of Monte Carlo outcome variance.

USFDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -20.7%

Equity Research

Archer-Daniels-Midland Company (ADM)

HOLD. 12-month probability-weighted target $77 (-4% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

ADMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -21.2%

Equity Research

Coca-Cola Consolidated Inc. (COKE)

HOLD. 12-month probability-weighted target $175 (-11% vs spot). Gross Margin explains 71% of Monte Carlo outcome variance.

COKEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -21.5%

Equity Research

The Coca-Cola Company (KO)

SELL. 12-month probability-weighted target $77 (-12% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

KOEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -21.6%

Equity Research

BJs Wholesale Club Holdings Inc (BJ)

HOLD. 12-month probability-weighted target $93 (-6% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

BJEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.2%

Equity Research

Keurig Dr Pepper Inc (KDP)

HOLD. 12-month probability-weighted target $31 (-3% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

KDPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.4%

Equity Research

Mondelez International Inc (MDLZ)

HOLD. 12-month probability-weighted target $58 (-4% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

MDLZEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -25.2%

Equity Research

Dollar General Corporation (DG)

HOLD. 12-month probability-weighted target $114 (-11% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

DGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -27.9%

Equity Research

Philip Morris International Inc (PM)

SELL. 12-month probability-weighted target $175 (-13% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

PMEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -28.1%

Equity Research

ELF Beauty Inc (ELF)

SELL. 12-month probability-weighted target $89 (-19% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

ELFEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -28.7%

Equity Research

Estee Lauder Companies Inc (EL)

SELL. 12-month probability-weighted target $79 (-20% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

ELEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -33.1%

Equity Research

The Marzetti Company (MZTI)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

MZTIEquity ResearchMonte Carlo

10 October 2026Rating: N/A